VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
MPT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
MPTMedical Properties Trust, Inc.
$1.81$1.1B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksMPTQuarterly Financials

Medical Properties Trust, Inc. (MPT) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Medical Properties Trust, Inc. (MPT) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

MPT Income Statement

Quarterly statement

MPT Income Statement

Medical Properties Trust, Inc. (MPT) annual income statement — 22-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Sales/Revenue250.14M259.28M252.06M270.34M237.52M240.36M223.8M235.27M225.83M266.56M271.32M-122.38M306.58M349.62M361.56M387.68M363.82M415.01M417.14M416.19M
Revenue Growth %5.31%7.87%12.63%14.91%5.18%-9.83%-----24.96%-131.57%-15.73%-15.76%-13.32%-6.85%-8.58%6.65%12.78%22.78%
Cost of Goods Sold11.4M150.11M9.94M9.52M8.99M10.86M7.04M9.78M4.99M7.66M4.82M3.3M6.48M24.68M7.11M7.7M8.27M21.14M8.6M7.83M
COGS % of Revenue4.56%57.89%3.94%3.52%3.79%4.52%3.14%4.16%2.21%2.87%1.78%-2.69%2.11%7.06%1.97%1.99%2.27%5.09%2.06%1.88%
Gross Profit238.74M109.17M242.13M260.82M228.53M229.5M216.76M225.49M220.83M258.9M266.5M-125.68M300.09M324.94M354.45M379.98M355.56M393.88M408.54M408.36M
Gross Margin %95.44%42.11%96.06%96.48%96.21%95.48%96.86%95.84%97.79%97.13%98.22%102.69%97.89%92.94%98.03%98.01%97.73%94.91%97.94%98.12%
Gross Profit Growth %4.47%-52.43%11.7%15.67%3.48%-11.36%-----24.81%-133.08%-15.6%-17.5%-13.24%-6.95%-9.03%6.32%12.11%22.54%
Operating Expenses123.25M-34.68M101.92M91.71M104.73M92.91M106.48M28.49M241.5M137.57M108.93M107.44M300.09M35.6M41.72M42.89M37.32M38.86M41.42M38.33M
OpEx % of Revenue49.27%-13.38%40.43%33.92%44.09%38.66%47.58%12.11%106.94%51.61%40.15%-87.79%97.89%10.18%11.54%11.06%10.26%9.36%9.93%9.21%
Selling, General & Admin29.04M34.77M32.2M24.59M37.73M26.2M41.91M28.49M36.63M35.33M33.35M30.15M38.11M35.6M41.72M42.89M37.32M38.86M41.42M38.33M
SG&A % of Revenue11.61%13.41%12.78%9.09%15.89%10.9%18.73%12.11%16.22%13.25%12.29%-24.64%12.43%10.18%11.54%11.06%10.26%9.36%9.93%9.21%
Research & Development0000000000----------
R&D % of Revenue--------------------
Other Operating Expenses1000K-1000K1000K1000K1000K1000K1000K01000K1000K----------
Operating Income115.49M143.86M140.2M169.11M123.8M136.58M110.28M197M-20.67M121.33M157.56M-233.13M0289.34M312.73M337.09M318.24M355.02M367.12M370.03M
Operating Margin %46.17%55.48%55.62%62.55%52.12%56.82%49.28%83.73%-9.15%45.52%58.07%190.49%-82.76%86.49%86.95%87.47%85.54%88.01%88.91%
Operating Income Growth %-6.71%5.33%27.13%-14.16%699.03%12.57%-----49.62%-169.16%-100%-18.5%-14.81%-8.9%-10.14%5.69%11.81%23.88%
EBITDA185.84M213.31M213.55M238.78M193.28M204.82M175.71M263.2M185.81M225.19M234.78M-153.2M314.31M657.31M400.31M421.95M402.88M442.33M455.88M457.69M
EBITDA Margin %74.29%82.27%84.72%88.33%81.37%85.21%78.51%111.87%82.28%84.48%86.53%125.18%102.52%188.01%110.72%108.84%110.73%106.58%109.29%109.97%
EBITDA Growth %-3.85%4.15%21.53%-9.28%4.02%-9.04%-----41.35%-136.31%-21.98%48.6%-12.19%-7.81%-8.97%6.59%12.02%22.43%
D&A (Non-Cash Add-back)70.34M69.45M73.35M69.67M69.48M68.24M65.43M66.2M206.47M103.86M77.21M79.93M80.65M367.97M87.59M84.86M84.64M87.32M88.76M87.66M
EBIT365.19M144.66M133.62M425.29M65.82M41.44M7.22M132.04M-685.65M-203.67M-755.74M-200.38M233.66M-75.06M228.87M255.63M236.37M270.68M281.8M285.83M
Net Interest Income-153.09M-135.26M-123.27M-122.49M-245.51M-129.53M-115.8M215.64M-106.24M-101.43M-108.69M-102.1M-105.85M-105.29M-97.65M-92.05M-88.09M-88.35M-100M-119.3M
Interest Income0010.06M9.96M000713K000000000000
Interest Expense153.09M135.26M133.33M132.46M245.51M129.71M115.8M-214.93M106.24M101.43M----------
Other Income/Expense96.61M-136.07M-139.92M-143.01M-190.38M-224.85M-218.86M-599.76M-771.23M-426.43M----------
Pretax Income212.1M7.79M285K26.1M-66.58M-88.27M-108.58M-402.76M-791.9M-305.1M-864.43M-659.6M126.95M-190.69M36.57M-124.93M240.6M200.72M643.33M211.65M
Pretax Margin %84.79%3%0.11%9.66%-28.03%-36.72%-48.52%-171.19%-350.67%-114.46%-318.61%538.97%41.41%-54.54%10.12%-32.22%66.13%48.37%154.22%50.85%
Income Tax10.03M10.08M-32.82M8.51M10.87M9.8M9.44M9.56M9.03M14.56M10.95M3.98M10.06M-148.26M3.54M15.29M18.58M10.66M11.38M4.81M
Effective Tax Rate %4.73%129.37%-11516.49%32.59%-16.33%-11.11%-8.69%-2.37%-1.14%-4.77%-1.27%-0.6%7.92%77.75%9.69%-12.24%7.72%5.31%1.77%2.27%
Net Income201.58M-2.6M32.83M17.31M-77.73M-98.36M-118.28M-412.85M-801.16M-320.63M-875.63M-663.94M116.71M-42.04M32.79M-140.47M221.79M189.6M631.68M206.54M
Net Margin %80.59%-1%13.02%6.4%-32.73%-40.92%-52.85%-175.48%-354.77%-120.29%-322.73%542.51%38.07%-12.02%9.07%-36.23%60.96%45.68%151.43%49.63%
Net Income Growth %359.34%97.36%127.75%104.19%90.3%69.32%-----2770.08%-372.64%-47.38%-122.17%-94.81%-168.01%29.6%65.49%285.68%87.96%
Net Income (Continuing)202.08M-2.29M33.11M17.6M-77.45M-98.07M-118.02M-412.32M-800.93M-319.66M-875.38M-663.58M116.89M-42.43M33.03M-140.21M222.02M190.06M631.95M206.84M
Discontinued Operations00000000000000000000
Minority Interest1.05M1.05M1.05M1.05M1.05M1.05M1.05M1.05M2.54M2.9M2.27M2.27M887K902K1.57M1.57M1.47M6.04M5.91M5.48M
EPS (Diluted)0.34-0.010.050.03-0.13-0.16-0.20-0.69-1.34-0.54-1.46-1.110.19-0.070.05-0.230.370.321.050.34
EPS Growth %361.54%96.88%127.1%104.1%90.3%70.37%-----2803.7%-382.61%-48.65%-122.19%-94.86%-167.65%27.59%68.42%275%70%
EPS (Basic)0.34-0.010.050.03-0.13-0.16-0.20-0.69-1.34-0.54-1.46-1.110.19-0.070.05-0.230.370.321.050.34
Diluted Shares Outstanding597.16M597.96M597.72M600.97M600.87M600.73M600.59M600.4M600.23M600.06M600.3M598.98M598.55M598.34M598.31M598.05M599.34M599.03M598.93M596.66M
Basic Shares Outstanding597.16M597.96M597.72M600.97M600.87M600.73M600.59M600.4M600.23M600.06M600.3M598.98M598.44M598.34M598.3M598.05M598.98M598.83M598.68M596.39M
Dividend Payout Ratio--168.61%279.67%--------148.96%-538.45%-78.46%91.79%27.94%80.97%